
Boundless Bio, Inc.
BOLDHealthcare|Biotechnology|US
$2.46
+0.05 (+2.07%)
Tangible Book / Share
$2.94
Cash / Share
$3.24
Ownership Breakdown
76.9%
Float
22.7M
Shares Outstanding
17.5M
Float Shares
Major Holders (15)
Combined: 87.4%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| FMR LLC | Holding company | 12.00% | 2,684,022 | Feb 5, 2026 | 13D/G |
| Abigail P. Johnson | Individual | 12.00% | 2,684,022 | Feb 5, 2026 | 13D/G |
| Tang Capital Management, LLC | Other | 11.30% | 2,533,845 | Jun 29, 2026 | 13D/G |
| Kevin Tang | Individual | 11.30% | 2,533,845 | Jun 29, 2026 | 13D/G |
| Zachary Hornby | Individual | 9.80% | 2,426,857 | Aug 27, 2026 | 13D/G |
| Daniel Schneeberger | HC, IN | 8.80% | 1,968,216 | Aug 14, 2026 | 13D/G |
| ADAR1 Capital Management, LLC | IA, OO | 8.80% | 1,968,216 | Aug 14, 2026 | 13D/G |
| Tang Capital Partners International, LP | Partnership | 3.50% | 791,839 | Jun 29, 2026 | 13D/G |
| Tang Capital Partners IV, Inc | Corporation | 2.60% | 580,669 | Jun 29, 2026 | 13D/G |
| Tang Capital Partners III, Inc | Corporation | 2.60% | 580,668 | Jun 29, 2026 | 13D/G |
| Tang Capital Partners, LP | Partnership | 2.60% | 580,669 | Jun 29, 2026 | 13D/G |
| Citadel Securities Group LP | HC, PN | 0.60% | 145,118 | Aug 14, 2026 | 13D/G |
| Kenneth Griffin | HC, IN | 0.60% | 145,118 | Aug 14, 2026 | 13D/G |
| Citadel Securities GP LLC | HC, OO | 0.60% | 145,118 | Aug 14, 2026 | 13D/G |
| Citadel Securities LLC | BD, OO | 0.30% | 65,617 | Aug 14, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 2,400,406 acquired · 82,300 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| TANG KEVIN | 10 percent owner | Nov 5, 2026 | BUY | 8,390 | $2.40 | $20.1K | Form 4 |
| TANG KEVIN | 10 percent owner | Nov 4, 2026 | BUY | 517 | $2.40 | $1.2K | Form 4 |
| TANG KEVIN | 10 percent owner | Nov 3, 2026 | BUY | 2,255 | $2.40 | $5.4K | Form 4 |
| TANG KEVIN | 10 percent owner | Oct 27, 2026 | BUY | 10,707 | $2.40 | $25.7K | Form 4 |
| TANG KEVIN | 10 percent owner | Oct 26, 2026 | BUY | 9,606 | $2.38 | $22.9K | Form 4 |
| TANG KEVIN | 10 percent owner | Oct 23, 2026 | BUY | 6,234 | $2.38 | $14.8K | Form 4 |
| TANG KEVIN | 10 percent owner | Oct 22, 2026 | BUY | 5,800 | $2.40 | $13.9K | Form 4 |
| TANG KEVIN | 10 percent owner | Oct 20, 2026 | BUY | 220 | $2.37 | $521.40 | Form 4 |
| TANG KEVIN | 10 percent owner | Oct 19, 2026 | BUY | 18,279 | $2.33 | $42.6K | Form 4 |
| TANG KEVIN | 10 percent owner | Oct 19, 2026 | BUY | 12,790 | $2.34 | $29.9K | Form 4 |
| TANG KEVIN | 10 percent owner | Oct 16, 2026 | BUY | 118,185 | $2.34 | $276.6K | Form 4 |
| TANG KEVIN | 10 percent owner | Aug 26, 2026 | SELL | 18,300 | $2.97 | $54.4K | Form 4 |
| TANG KEVIN | 10 percent owner | Jul 21, 2026 | BUY | 2,975 | $2.44 | $7.3K | Form 4 |
| TANG KEVIN | 10 percent owner | Jul 20, 2026 | BUY | 1,623 | $2.44 | $4.0K | Form 4 |
| TANG KEVIN | 10 percent owner | Jul 17, 2026 | BUY | 265 | $2.44 | $646.60 | Form 4 |
| TANG KEVIN | 10 percent owner | Jul 16, 2026 | BUY | 18,491 | $2.44 | $45.1K | Form 4 |
| TANG KEVIN | 10 percent owner | Jul 15, 2026 | BUY | 1,600 | $2.44 | $3.9K | Form 4 |
| TANG KEVIN | 10 percent owner | Jul 14, 2026 | BUY | 43,878 | $2.43 | $106.6K | Form 4 |
| TANG KEVIN | 10 percent owner | Jul 13, 2026 | BUY | 48,211 | $2.42 | $116.7K | Form 4 |
| TANG KEVIN | 10 percent owner | Jul 10, 2026 | BUY | 43,367 | $2.43 | $105.4K | Form 4 |
| TANG KEVIN | 10 percent owner | Jul 9, 2026 | BUY | 7 | $2.48 | $17.36 | Form 4 |
| TANG KEVIN | 10 percent owner | Jul 8, 2026 | BUY | 14,338 | $2.46 | $35.3K | Form 4 |
| TANG KEVIN | 10 percent owner | Jul 7, 2026 | BUY | 15,810 | $2.48 | $39.2K | Form 4 |
| TANG KEVIN | 10 percent owner | Jul 6, 2026 | BUY | 27,062 | $2.49 | $67.4K | Form 4 |
| CRANDELL KEITH | 10 percent owner | Jul 1, 2026 | OPTION EX. | 16,000 | $1.03 | $16.5K | Form 4 |
| CRANDELL KEITH | 10 percent owner | Jul 1, 2026 | SELL | 16,000 | $2.49 | $39.8K | Form 4 |
| CRANDELL KEITH | 10 percent owner | Jul 1, 2026 | OPTION EX. | 16,000 | $1.03 | $16.5K | Form 4 |
| ARCH Venture Fund IX, L.P. | 10 percent owner | Jul 1, 2026 | OPTION EX. | 16,000 | $1.03 | $16.5K | Form 4 |
| ARCH Venture Fund IX, L.P. | 10 percent owner | Jul 1, 2026 | SELL | 16,000 | $2.49 | $39.8K | Form 4 |
| ARCH Venture Fund IX, L.P. | 10 percent owner | Jul 1, 2026 | OPTION EX. | 16,000 | $1.03 | $16.5K | Form 4 |
| TANG KEVIN | 10 percent owner | Jul 2, 2026 | BUY | 9,821 | $2.49 | $24.5K | Form 4 |
| TANG KEVIN | 10 percent owner | Jul 1, 2026 | BUY | 71,612 | $2.49 | $178.3K | Form 4 |
| TANG KEVIN | 10 percent owner | Jun 30, 2026 | BUY | 100 | $2.50 | $250.00 | Form 4 |
| TANG KEVIN | 10 percent owner | Jun 30, 2026 | BUY | 25,930 | $2.54 | $65.9K | Form 4 |
| TANG KEVIN | 10 percent owner | Jun 29, 2026 | BUY | 777 | $2.48 | $1.9K | Form 4 |
| TANG KEVIN | 10 percent owner | Jun 29, 2026 | BUY | 63,985 | $2.47 | $158.0K | Form 4 |
| TANG KEVIN | 10 percent owner | Jun 26, 2026 | BUY | 134 | $2.54 | $340.36 | Form 4 |
| TANG KEVIN | 10 percent owner | Jun 26, 2026 | BUY | 75,047 | $2.55 | $191.4K | Form 4 |
| TANG KEVIN | 10 percent owner | Jun 25, 2026 | BUY | 510 | $2.56 | $1.3K | Form 4 |
| TANG KEVIN | 10 percent owner | Jun 25, 2026 | BUY | 145,880 | $2.48 | $361.8K | Form 4 |
| TANG KEVIN | 10 percent owner | Jun 25, 2026 | OTHER | 0 | — | — | Form 4 |
| Whiting Nancy | director | Jun 15, 2026 | AWARD | 32,000 | $1.40 | $44.8K | Form 4 |
| Lim Jonathan E | director | Jun 15, 2026 | AWARD | 48,000 | $1.40 | $67.2K | Form 4 |
| Christensen James | director | Jun 15, 2026 | AWARD | 32,000 | $1.40 | $44.8K | Form 4 |
| Lew Jennifer | director | Jun 15, 2026 | AWARD | 32,000 | $1.40 | $44.8K | Form 4 |
| Oien Jessica | See Remarks | Jan 23, 2026 | AWARD | 220,000 | $1.26 | $277.2K | Form 4 |
| Hassig Christian | Chief Scientific Officer | Jan 23, 2026 | AWARD | 230,000 | $1.26 | $289.8K | Form 4 |
| Doebele Robert | Chief Medical Officer | Jan 23, 2026 | AWARD | 230,000 | $1.26 | $289.8K | Form 4 |
| Hornby Zachary | director, officer: President & CEO | Jan 23, 2026 | AWARD | 600,000 | $1.26 | $756.0K | Form 4 |
| HINKLE DAVID A | See Remarks | Jan 23, 2026 | AWARD | 140,000 | $1.26 | $176.4K | Form 4 |
| Brennan Christine | director | Jun 23, 2025 | AWARD | 16,000 | $1.03 | $16.5K | Form 4 |
| Christensen James | director | Jun 23, 2025 | AWARD | 16,000 | $1.03 | $16.5K | Form 4 |
| Lew Jennifer | director | Jun 23, 2025 | AWARD | 16,000 | $1.03 | $16.5K | Form 4 |
| Lim Jonathan E | director | Jun 23, 2025 | AWARD | 24,000 | $1.03 | $24.7K | Form 4 |
| Burow Kristina | director, 10 percent owner: | Jun 23, 2025 | AWARD | 16,000 | $1.03 | $16.5K | Form 4 |
| Whiting Nancy | director | Jun 23, 2025 | AWARD | 16,000 | $1.03 | $16.5K | Form 4 |
| Doebele Robert | Chief Medical Officer | Feb 3, 2025 | AWARD | 180,000 | $2.23 | $401.4K | Form 4 |
| Doebele Robert | Feb 3, 2025 | OTHER | 0 | — | — | Form 4 | |
| HINKLE DAVID A | See Remarks | Jan 22, 2025 | AWARD | 65,000 | $2.57 | $167.1K | Form 4 |
| Hassig Christian | Chief Scientific Officer | Jan 22, 2025 | AWARD | 95,000 | $2.57 | $244.1K | Form 4 |
| Hornby Zachary | director, officer: President & CEO | Jan 22, 2025 | AWARD | 295,000 | $2.57 | $758.1K | Form 4 |
| Oien Jessica | See Remarks | Jan 22, 2025 | AWARD | 90,000 | $2.57 | $231.3K | Form 4 |
| HINKLE DAVID A | See Remarks | Oct 11, 2024 | OTHER | 0 | — | — | Form 4 |
| HINKLE DAVID A | See Remarks | Oct 11, 2024 | OTHER | 13,915 | — | — | Form 4 |
| Hassig Christian | Chief Scientific Officer | Aug 19, 2024 | AWARD | 94,871 | $3.56 | $337.7K | Form 4 |
| Hassig Christian | Chief Scientific Officer | Aug 19, 2024 | AWARD | 76,173 | $3.56 | $271.2K | Form 4 |
| Hassig Christian | Chief Scientific Officer | Aug 19, 2024 | AWARD | 62,820 | $3.56 | $223.6K | Form 4 |
| Hassig Christian | Chief Scientific Officer | Aug 19, 2024 | AWARD | 48,703 | $3.56 | $173.4K | Form 4 |
| Hassig Christian | Chief Scientific Officer | Aug 19, 2024 | AWARD | 10,256 | $3.56 | $36.5K | Form 4 |
| Hassig Christian | Chief Scientific Officer | Aug 19, 2024 | DISPOSED | 10,256 | $3.71 | $38.0K | Form 4 |
| Hassig Christian | Chief Scientific Officer | Aug 19, 2024 | DISPOSED | 48,703 | $16.00 | $779.2K | Form 4 |
| Hassig Christian | Chief Scientific Officer | Aug 19, 2024 | DISPOSED | 76,173 | $8.19 | $623.9K | Form 4 |
| Hassig Christian | Chief Scientific Officer | Aug 19, 2024 | DISPOSED | 94,871 | $4.10 | $389.0K | Form 4 |
| Oien Jessica | See Remarks | Aug 19, 2024 | AWARD | 42,051 | $3.56 | $149.7K | Form 4 |
| Oien Jessica | See Remarks | Aug 19, 2024 | AWARD | 35,897 | $3.56 | $127.8K | Form 4 |
| Oien Jessica | See Remarks | Aug 19, 2024 | AWARD | 32,051 | $3.56 | $114.1K | Form 4 |
| Oien Jessica | See Remarks | Aug 19, 2024 | AWARD | 29,148 | $3.56 | $103.8K | Form 4 |
| Oien Jessica | See Remarks | Aug 19, 2024 | AWARD | 26,090 | $3.56 | $92.9K | Form 4 |
| Oien Jessica | See Remarks | Aug 19, 2024 | AWARD | 16,234 | $3.56 | $57.8K | Form 4 |
| Oien Jessica | See Remarks | Aug 19, 2024 | AWARD | 10,200 | $3.56 | $36.3K | Form 4 |
| Oien Jessica | See Remarks | Aug 19, 2024 | DISPOSED | 16,234 | $16.00 | $259.7K | Form 4 |
| Oien Jessica | See Remarks | Aug 19, 2024 | DISPOSED | 26,090 | $8.19 | $213.7K | Form 4 |
| Oien Jessica | See Remarks | Aug 19, 2024 | DISPOSED | 35,897 | $4.49 | $161.2K | Form 4 |
| Oien Jessica | See Remarks | Aug 19, 2024 | DISPOSED | 42,051 | $4.10 | $172.4K | Form 4 |
| Hornby Zachary | director, officer: President & CEO | Aug 19, 2024 | AWARD | 471,282 | $3.56 | $1.7M | Form 4 |
| Hornby Zachary | director, officer: President & CEO | Aug 19, 2024 | AWARD | 257,207 | $3.56 | $915.7K | Form 4 |
| Hornby Zachary | director, officer: President & CEO | Aug 19, 2024 | AWARD | 256,410 | $3.56 | $912.8K | Form 4 |
| Hornby Zachary | director, officer: President & CEO | Aug 19, 2024 | AWARD | 162,343 | $3.56 | $577.9K | Form 4 |
| Hornby Zachary | director, officer: President & CEO | Aug 19, 2024 | DISPOSED | 257,207 | $8.19 | $2.1M | Form 4 |
| Hornby Zachary | director, officer: President & CEO | Aug 19, 2024 | DISPOSED | 471,282 | $4.10 | $1.9M | Form 4 |
| Hornby Zachary | director, officer: President & CEO | Aug 19, 2024 | DISPOSED | 162,343 | $16.00 | $2.6M | Form 4 |
| Abdollahian Neil | Chief Business Officer | Aug 19, 2024 | AWARD | 82,051 | $3.56 | $292.1K | Form 4 |
| Abdollahian Neil | Chief Business Officer | Aug 19, 2024 | AWARD | 54,871 | $3.56 | $195.3K | Form 4 |
| Abdollahian Neil | Chief Business Officer | Aug 19, 2024 | AWARD | 36,852 | $3.56 | $131.2K | Form 4 |
| Abdollahian Neil | Chief Business Officer | Aug 19, 2024 | AWARD | 23,191 | $3.56 | $82.6K | Form 4 |
| Abdollahian Neil | Chief Business Officer | Aug 19, 2024 | AWARD | 19,948 | $3.56 | $71.0K | Form 4 |
| Abdollahian Neil | Chief Business Officer | Aug 19, 2024 | DISPOSED | 23,191 | $16.00 | $371.1K | Form 4 |
| Abdollahian Neil | Chief Business Officer | Aug 19, 2024 | DISPOSED | 36,852 | $8.19 | $301.8K | Form 4 |
| Abdollahian Neil | Chief Business Officer | Aug 19, 2024 | DISPOSED | 54,871 | $4.10 | $225.0K | Form 4 |
| Wagner Klaus W. | Chief Medical Officer | Aug 19, 2024 | AWARD | 102,564 | $3.56 | $365.1K | Form 4 |